✦ LIBER ✦

Safety and Tolerability of Increased Rate of Infusion of Intravenous Immunoglobulin G, 10% in Antibody-Deficient Patients

✍ Scribed by Erwin W. Gelfand; Kim Hanna; The IGIV-C Increased Maximum Infusion Rate Study Group

Book ID: 106405638
Publisher: Springer
Year: 2006
Tongue: English
Weight: 203 KB
Volume: 26
Category: Article
ISSN: 0271-9142
DOI: 10.1007/s10875-006-9014-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and tolerability of a novel chrom

Safety and tolerability of a novel chromatography-based intravenous immunoglobulin when administered at a high infusion rate in patients with immune thrombocytopenic purpura

✍ James B. Bussel; Kim Hanna 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 2 views

## Abstract Intravenous immunoglobulin (IGIV) therapy is generally considered to be a safe and effective treatment for idiopathic thrombocytopenic purpura (ITP). The usual initial treatment dose is 1–2 g/kg body weight, which results in an extended infusion time, significantly impacting patients' d

Safety and tolerability of intravenous f

Safety and tolerability of intravenous ferric carboxymaltose in patients with iron deficiency anemia

✍ George R. BAILIE; Nancy A. MASON; Thomas G. VALAORAS 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB

Efficacy, Pharmacokinetics, Safety, and

Efficacy, Pharmacokinetics, Safety, and Tolerability of Flebogamma® 10% DIF, a High-Purity Human Intravenous Immunoglobulin, in Primary Immunodeficiency

✍ Melvin Berger; Paul J. Pinciaro; Arthur Althaus; Mark Ballow; Akhilesh Chouksey; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 181 KB

Efficacy, Safety and Tolerability of a N

Efficacy, Safety and Tolerability of a New 10% Liquid Intravenous Immune Globulin [IGIV 10%] in Patients with Primary Immunodeficiency

✍ Joseph A. Church; Heinz Leibl; Mark R. Stein; Isaac R. Melamed; Arye Rubinstein; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 443 KB

Efficacy and Tolerability of an Argentin

Efficacy and Tolerability of an Argentine Intravenous Immunoglobulin in Pediatric Patients with Primary Immunodeficiency Diseases

✍ S. Krasovec; A. Ornani; M. Oleastro; S. Rosenzweig; A. Roy; L. Perez; G. Campos; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 175 KB

Safety and Efficacy of Privigen®, a Nove

Safety and Efficacy of Privigen®, a Novel 10% Liquid Immunoglobulin Preparation for Intravenous Use, in Patients with Primary Immunodeficiencies

✍ Mark R. Stein; Robert P. Nelson; Joseph A. Church; Richard L. Wasserman; Michael 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 166 KB